Organogenesis Holdings Inc. ORGO Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 0.5%— | 7.9%— | —— | —— | —— | |
| Net margin | 0.5%+4.0pp | 6.6%+6.4pp | 0.2%— | -1.9%— | -3.5%— | |
| Returns | ||||||
| Return on equity | 1.1%+7.2pp | 13.2%+12.8pp | 0.4%— | -3.3%— | -6.1%— | |
| Return on invested capital | 0.9%— | 12.4%— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1×+0.1× | 1×0.0× | 1×0.0× | 1×-0.1× | 1×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.5×-0.6× | 3.6×-0.1× | 3.3×+0.2× | 4×+1.2× | 4.1×+1.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.3×-0.2× | 0.1×-0.2× | 0.1×-0.3× | 0.1×-0.3× | |
| Net debt / EBITDA | -2.8×— | -0×— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $1.91-0.5% | $2.30+15.4% | $1.95-6.3% | $1.74-12.4% | $1.92-8.8% | |
| Valuation | ||||||
| Market capitalization | $312.68M-23.7% | $657.4M+63.4% | $535.34M+41.2% | $438.91M+18.9% | $547.9M+47.4% | |
| Price / earnings | 115×— | 17.8×-450× | 532.7×— | —— | —— | |
| Price / sales | 0.6×-0.3× | 1.2×+0.3× | 1.2×+0.3× | 1×+0.2× | 1.2×+0.3× | |
| Price / book | 1.3×-0.4× | 2.2×+0.7× | 2.1×+0.7× | 1.9×+0.5× | 2.3×+0.9× | |
| EV / EBITDA | 14.1×— | 10.9×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Organogenesis Holdings Inc.'s profit margins?
- Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.
- Where do Organogenesis Holdings Inc.'s ratios come from?
- Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
